L632-0679 Screening compound: 2-(4-methoxyphenyl)-1-(1-methyl-3-{[3-(1-pyrrolidinylcarbonyl)piperidino]carbonyl}-1,4,6,7-tetrahydro-5H-pyrazolo[4,3-c]pyridin-5-yl)-1-ethanone

L632-0679 Screening compound: 2-(4-methoxyphenyl)-1-(1-methyl-3-{[3-(1-pyrrolidinylcarbonyl)piperidino]carbonyl}-1,4,6,7-tetrahydro-5H-pyrazolo[4,3-c]pyridin-5-yl)-1-ethanone
L632-0679 Screening compound: 2-(4-methoxyphenyl)-1-(1-methyl-3-{[3-(1-pyrrolidinylcarbonyl)piperidino]carbonyl}-1,4,6,7-tetrahydro-5H-pyrazolo[4,3-c]pyridin-5-yl)-1-ethanone alternative view

Chemical Structure Depiction of ChemDiv screening compound L632-0679
2-(4-methoxyphenyl)-1-(1-methyl-3-{[3-(1-pyrrolidinylcarbonyl)piperidino]carbonyl}-1,4,6,7-tetrahydro-5H-pyrazolo[4,3-c]pyridin-5-yl)-1-ethanone

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L632-0679

Molecular Formula

C27H35N5O4 (C27 H35 N5 O4)

Compound Name

2-(4-methoxyphenyl)-1-(1-methyl-3-{[3-(1-pyrrolidinylcarbonyl)piperidino]carbonyl}-1,4,6,7-tetrahydro-5H-pyrazolo[4,3-c]pyridin-5-yl)-1-ethanone

IUPAC name

2-(4-methoxyphenyl)-1-{1-methyl-3-[3-(pyrrolidine-1-carbonyl)piperidine-1-carbonyl]-1H4H5H6H7H-pyrazolo[43-c]pyridin-5-yl}ethan-1-one

SMILES

Cn1nc(C(N(CCC2)CC2C(N2CCCC2)=O)=O)c(C2)c1CCN2C(Cc(cc1)ccc1OC)=O

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

493.61

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

1.453

Distribution Coefficient, logD

1.453

Water Solubility, LogSw

-1.93

Polar Surface Area

72.179

Acid Dissociation Constant (pKa)

17.36

Base Dissociation Constant (pKb)

3.51

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

55.56

L632-0679 in Drug Discovery

Included in Screening Libraries

Cysteine Proteases Inhibitors Library (7839 compounds)

GPCR Targeted Library (31838 compounds)

Hsp90-Targeted Library (11355 compounds)

Targeted Diversity Library (40567 compounds)

Anti-HIV1 Library (19540 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Nervous system
  • Cardiovascular
  • Skin
  • Metabolic
  • Endocrine
  • Immune system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Immune system
  • Antiviral
  • Infections
  • Immune system
Targets:
  • Proteases
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with L632-0679 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L632-0679?
Check Price and Availability of L632-0679, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L632-0679 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L632-0679
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L632-0679
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L632-0679 available by request